Social Determinants of Sleep and Obesity
Launched by UNIVERSITY OF MINNESOTA · Jan 16, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Social Determinants of Sleep and Obesity," is focused on understanding how sleep affects health, particularly for African American adults who may not be getting enough quality sleep. Research shows that many African American adults sleep less than the national average, which can lead to serious health issues like obesity and diabetes. The main goal of this study is to create a program that helps improve sleep and physical activity for African American adults who are overweight and not meeting health guidelines. By doing this, the researchers hope to reduce health problems related to obesity and cancer in this community.
To be eligible for this study, participants should be between 21 and 65 years old, identify as Black or African American, have a body mass index (BMI) between 25 and 40, and typically sleep for 6 hours or less each night. They should also not be following the recommended levels of physical activity. Participants will have the chance to engage in a sleep intervention designed specifically for their needs, and they will work with researchers to help improve their sleep habits and overall health. If you're interested and meet the criteria, this could be a valuable opportunity to contribute to important health research while also working on your own well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Not meeting Physical Activity Guidelines
- • age range: 21 to 65 years
- • body mass index range: 25.0 to 40 kg/m2
- • average self-reported habitual sleep duration of ≤6 hours
- • self-identify as Black or African American.
- Exclusion Criteria:
- • Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophageal disorder)
- • pregnant or less than 4 months postpartum
- • infant living in household less than 1 year old
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Trial Officials
Ivan Wu
Principal Investigator
University of Minnesota
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials